Related Experiment Videos
Single daily dose ceftriaxone therapy in epiglottitis
G J Knight1, M A Harris, M Parbari
1Mater Children's Hospital, South Brisbane, Queensland, Australia.
Journal of Paediatrics and Child Health
|June 1, 1992
Summary
Single daily intravenous ceftriaxone effectively treated pediatric Haemophilus influenzae epiglottitis. This antibiotic demonstrated favorable outcomes, minimal side effects, and potential clinical and economic benefits for managing this serious infection.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Pharmacology
Background:
- Epiglottitis is a severe upper airway infection primarily caused by Haemophilus influenzae.
- Prompt and effective antibiotic treatment is crucial for managing epiglottitis and preventing complications.
Purpose of the Study:
- To evaluate the efficacy and safety of ceftriaxone in treating pediatric patients with confirmed Haemophilus influenzae epiglottitis.
Main Methods:
- Seven pediatric patients with proven Haemophilus influenzae epiglottitis were treated.
- Treatment involved a single daily intravenous dose of ceftriaxone for five days.
- Serum drug levels and clinical responses were monitored.
Main Results:
- All seven children showed a favorable clinical response to ceftriaxone treatment.
- Achieved serum ceftriaxone levels significantly exceeded the minimum inhibitory concentration (MIC) against Haemophilus influenzae.
- Side effects were mild, transient, and did not necessitate treatment discontinuation.
Conclusions:
- Ceftriaxone is an effective and safe treatment option for pediatric Haemophilus influenzae epiglottitis.
- The drug's pharmacokinetic profile supports its use in a single daily dose regimen.
- Ceftriaxone presents potential clinical and economic advantages in epiglottitis management.